Chinese Medicine Regulatory Office

The Department of General Affairs of the National Medical Products Administration Issued the "Implementation Plan for Supporting Hong Kong and Macau Drug Marketing Authorization Holders to Produce Drugs in 9 Mainland Cities of the Greater Bay Area"

On 23 June 2022, the Department of General Affairs of the National Medical Products Administration issued the "Implementation Plan for Supporting Hong Kong and Macau Drug Marketing Authorization Holders to Produce Drugs in 9 Mainland Cities of the Greater Bay Area". The implementation plan clarifies the work objectives, division of responsibilities, application scope, work procedures, application materials, and job requirements for Hong Kong and Macau drug marketing authorization holders to produce drugs in 9 Mainland Cities of the Greater Bay Area. For details, please visit the website of the National Medical Products Administration: https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjzh/20220629171101193.html